Picture of Amplia Therapeutics logo

ATX — Amplia Therapeutics News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Australia's Amplia Therapeutics slips on discounted capital raise

** Amplia Therapeutics ATX.AX slips as much as 14% to A$0.245, lowest since July 4

** Stock marks biggest intraday pct drop since June 30

** Drug developer announces capital raise of A$27.5 mln ($18 mln) at issue price of A$0.23, representing 19.3% discount to last close

** Says funds will support ACCENT and AMPLICITY trials, support ovarian cancer trials of co's lead drug, narmafotinib (AMP945

** Stock last down 10.5%, trims YTD gains to ~192%

($1 = A$1.5253)

 (Reporting by Anjali Singh in Bengaluru)

 ((anjali.singh2@thomsonreuters.com;))

Recent news on Amplia Therapeutics

See all news